The Czech Republic has a relatively long tradition in the addictive and problem use of methamphetamine, which is called “pervitin” locally. This paper attempts to provide as complex a picture of this phenomenon as possible by analyzing what is known about the Czech methamphetamine situation through scientific monitoring and research. It begins with a brief historical overview and then utilizes five key indicators (surveys, treatment demand, problem drug use estimates, blood borne diseases, and mortality) and some of the core indicators (namely, drug related crime, price and purity data, and estimates of market value) of drug epidemiology that were developed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). By summarizing and carefully interpreting this data, the specifics of the Czech pervitin scene are described and future research directions are identified.
Get full access to this article
View all access options for this article.
References
1.
Advisory Council on the Misuse of Drugs2005Methamphetamine review 2005: Executive summary (1st ed.). London: ACMD.
2.
BrožováJ.ÚZIS2006Výběrové šetření o zdravtním stavu a životním stylu obyvatel České republiky zaměřené na zneužívání drog (Sample survey of he health status and live style of the population in the Czech Republic focused on drug abuse) (1st ed.). Praha: Ústav zdravotnických informací a statistiky.
3.
BushW.RobertsM.TraceM.2004Australian drug market: Heroin drought, stimulant flood. London: Drugscope and the Beckley Foundation.
4.
CaseP.2005The history of methamphetamine: An epidemic in context. The First National Conference on Methamphetamine, HIV and Hepatitis. Salt Lake City: The Harm Reduction Project.
5.
CaulkinsJ. P.ReuterP.1998What price data tell us about drug markets. Journal of Drug Issues, 28 (3), 593–612.
6.
CsémyL.SovinováH.KomárekJ.2000Drogy a taneční scéna (Drugs and the dance scene). Praha: Státní zdravotní ústav.
7.
DegenhardtL.HallW.Warner-SmithM.2006Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS. Sexually Transmitted Infections, 82 (Suppl 3), iii56–63.
8.
DoyleD.2005Adolf Hitler's medical care. J R Coll Physicians Edinb, 35, 75–82.
9.
European Monitoring Centre for Drugs and Drug Addiction2002aThe DRD-Standard, version 3.0. Lisbon: EMCDDA.
10.
European Monitoring Centre for Drugs and Drug Addiction2002bHandbook for surveys on drug use among the general population. EMCDDA project CT.99.EP.08 B.Lisbon: EMCDDA.
European Monitoring Centre for Drugs and Drug Addiction2005Výroční zpráva za rok 2005: Stav drogové problematiky v Evropské unii a Norsku (2005 annual report on the state of the drugs problem in the European Union and Norway). Luxembourg: Office for Official Publications of the European Communities.
13.
European Monitoring Centre for Drugs and Drug Addiction2006Výroční zpráva za rok 2006: Stav drogové problematiky v Evropské unii a Norsku (2006 annual report on the state of the drugs problem in the European Union and Norway). Luxembourg: Office for Official Publications of the European Communities.
14.
EMCDDA & Institute for Therapy Research1998Study to obtain comparable national estimates of problem drug use prevalence for all EU member states. (Report No. EMCDDA Project (CT.97. EP.04)). Lisboa/Munchen: EMCDDA.
15.
GajdošíkováH.2001Historický nástin právní úpravy drogových trestných činů na historickém území Čech, Moravy a Slezska (Historical Outline of the legislative arrangements concerning Drug-related criminal offences in the historical premises of Bohemia, Moravia and Silesia). Adiktologie Supplementum, 1 (1), 14–21.
16.
GlasováA. & Centrum pro výzkum veřejného mínění2002Problematika drog očima veřejnosti (Drugs in view of public). Praha: CVVM.
17.
HoyertD. L.HeronM. P.MurhyS. L.KungH.-C.2006Deaths: Final data for 2003. Hyatsville, MD: National Center for Health Statistics.
18.
JaníkA.DušekK.1990Drogy a společnost [Drugs and society] (1st ed.). Praha: Avicenum.
KellyB. C.ParsonsJ. T.WellsB. E.2006Prevalence and predictors of club drug use among club-going young adults in New York city. Journal of Urban Health, 83 (5), 884–95.
21.
KoestersS. C.RogersP. D.RajasinghamC. R.2002MDMA (‘ecstasy”) and other ‘club drug's. The new epidemic. Pediatric Clinics of North America, 49 (2), 415–33.
22.
KubůP.KřížováE.CsémyL.2000Anketa semtex dance 2000, pp. 24–30. Praha: imédia s.r.o.
23.
KubůP.ŠkařupováK.CsémyL.2006Tanec a drogy 2000 a 2003: Výsledky dotazníkové studie s příznivci elektronické taneční hudby v České republice (Dance and drugs 2000 and 2003 - Results of the questionnaire survey in fans of electronic dance music in the Czech Republic) (1st ed.). (Výzkumná zpráva No. 2). Praha: Úřad vlády ČR.
24.
KulsudjaritK.2004Drug problem in Southeast and Southwest Asia. Annals of the New York Academy of Sciences, 1025 (1), 446–457.
25.
LongoM. C.Henry-EdwardsS. M.HumeniukR. E.ChristieP.AliR. L.2004Impact of the heroin ‘drought’ on patterns of drug use and drug-related harms. Drug and Alcohol Review, 23 (2), 143–50.
26.
MarekB.2002Author's personal communication with ex-head of the Drugs and Weapons Department of the General Directorate of Customs.
27.
MaxwellJ. C.2005Party drugs: Properties, prevalence, patterns, and problems. Substance Use and Misuse, 40 (9–10), 1203–40.
28.
McCambridgeJ.WinstockA.HuntN.MitchesonL.2007Five-year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. European Addiction Research, 13 (1), 57–64.
29.
McKetinR.McLarenJ.KellyE.HallW.HickmanM.2005Estimating the number of regular and dependent methamphetamine users in Australia. (Report No. 130). National Drug & Alcohol Research Centre.
30.
MillerC. L.KerrT.StrathdeeS. A.LiK.WoodE.2007Factors associated with premature mortality among young injection drug users in Vancouver. Harm Reduction Journal, 4, 1.
MiovskýM.ZábranskýT.2001Přehled výsledků substudie provedené s uživateli nelegálních psychoaktivních látek a pracovníky zdravotnických zařízení a významnými poskytovateli služeb uživatelům nelegálních drog (Summary of results of a substudy carried out with users of illicit psychoactive drugs and workers at medical facilities and significant providers of services for illicit drug users). Adiktologie Suplementum, 1 (1), 41–75.
33.
MravčíkV.PetrošO.ZábranskýT.BerzsiG.MalinováH.ŠvecJ.HronováS.RojíčekM.SixtaJ.HolikováN.ChladM.VopravilJ.2005Project data collection: Illegal activities. Luxembourg: CIRCA—a collaborative workspace with partners of the European institutions.
34.
MravčíkV.KorčišováB.LejčkováP.MiovskáL.ŠkrdlantováE.PetrošO.RadimeckýJ.SklenářV.GajdošíkováH.VopravilJ.2004Výroční zpráva o stavu ve věcech drog v České republice v roce 2003 (The Czech Republic: Drug situation 2003) Praha: Úřad vlády ČR (Office of the Czech Government).
35.
MravčíkV.LejčkováP.OrlíkováB.PetrošováB.ŠkrdlantováE.TrojáčkováA.PetrošO.SklenářV.VopravilJ.2006Výroční zpráva o stavu ve věcech drog v České republice v roce 2005 (The Czech Republic: Drug situation 2005) Praha: Úřad vlády ČR (Office of the Czech Government).
36.
MravčíkV.ZábranskýT.2001Sekundární analýza školních studií 1994–2000 (Secondary Analysis of School Surveys 1994–2000 in Czech Republic). Adiktologie Suplementum, 1 (1), 108–123.
37.
MravčíkV.ZábranskýT.2002Prevalenční odhad problémových uživatelů drog v ČR - syntéza dostupných dat (The prevalence estimate of problem drug use in Czech Republic - synthesis of avilable data). Adiktologie Suplementum, 1 (1), 22–43.
38.
National Police Drug Squad2002Výroční zpráva - Situace v oblasti drog v roce 2001 v České republice (Annual report 2001: Illicit drugs situation in Czech Republic 2001). Praha: Policie ČR.
39.
National Police Drug Squad2006Výroční zpráva 2005 (Annual report: Illicit drugs situation in Czech Republic 2005). Praha: Policie ČR.
40.
Národní protidrogová centrála Policie ČR2004Výroční zpráva NPDC za rok 2003 (National (Police) Drug Squad Annual Report 2003) Retrieved December 9, 2006, from http://www.mvcr.cz/policie/npdc/r2003_policie.html.
41.
NožinaM.1997Drogová historie (Drug history). In NožinaM. (Principle Author), Svět drog v Čechách (The world of drugs in Czechia) (1st ed.) (pp. 49–126). Praha & Orlík nad Vltavou: KLP-Koniasch Latin Press & Livingstone.
42.
OgataA.1919Constitution of ephedrine-desoxyephedrine. Journal of the Pharmaceutical Society of Japan, (451), 751–764.
43.
Okruhlica2003 Personal communication.
44.
PetrošO.MravčíkV.Korčišová-PetrošováB.2005Spotøeba drog problémovými uživateli (The consumption of illicit drugs by problem users). Adiktologie, 5 (1), 4–12.
Statens Folkhälsoinstitut20052005 national report (2004 data) to the EMCDDA by the Reitox National Focal Point- Sweden: New development, trends and in-depth information on selected issues (1st ed.). Stockholm: Statens Folkhälsoinstitut.
47.
StudničkováB.KlepetkováM.ŠeblováJ.ZemanováR.2006Výroční zpráva ČR 2005-incidence, prevalence, zdravotní dopady a trendy léčených uživatelů drog (Annual report CR 2005-incidence, prevalence, health impact and trends of drug users in treatment). Praha: HS hl. m. Prahy (Prague Hygienic Station).
48.
Substance Abuse and Mental Health Services Administration, Office of Applied Studies2005Treatment Episode Data Set (TEDS) 1994–2004. National admissions to substance abuse treatment services. (1st ed.) (DASIS Series No. S-33). Rockville, MD: National Clearinghouse for Alcohol and Drug Information.
49.
SuwakiH.1991The methamphetaminie abuse in Japan. In MillerM. A.KozelN. J. (Eds.), Methamphetamine abuse: Epidemiologic issues and implications (pp. 84–96). Rockville, MD: NIDA.
50.
TanneJ. H.2006Methamphetamine epidemic hits middle America. British Medical Journal, 332 (7538), 382.
51.
TossmannP.BoldtS.TensilM. D.2001The use of drugs within the techno party scene in European metropolitan cities. European Addiction Research, 7 (1), 2–23.
52.
United Nations Office on Drugs and Crime20062005 world drug report: Volume 1 (1st ed.). Vienna: United Nations Office for Drugs and Crime.
53.
VantuchP.1990Drogy a kriminalita (Drugs and criminality) (1st ed.). Brno: Právnická fakulta J.E. Purkyně v Brně.
54.
VincenteJ.HartnollR.SimonR.PfeifferT.StauffacherM.2000Key epidemiological indicator: Demand for treatment by drug users. Lisbon: EMCDDA & Pompidou Group.
VopravilJ.Český statistický úřad2005Nelegální ekonomika v ČR 2003 (Czech illegal economy in 2003). Praha: Český statistický úřad.
57.
YamamotoJ.2004Recent trends of drug abuse in Japan. Annals of the New York Academy of Sciences, 1025, 430–8.
58.
ZábranskýT.2004aCzech drug laws as arena of drug policy battle. Journal of Drug Issues, 34(3), 661–686.
59.
ZábranskýT.2004bDrogová epidemiologie (Drug epidemiology) (1st ed.). Olomouc: Nakladatelství Univerzity Palackého.
60.
ZábranskýT.2004cÚmrtí z předávkování ilegálními drogami v ČR 1998–2003 a jejich situční kontext (Fatal drug overdoses in the Czech Republic 1998–2003 and situational context). In ZábranskýT. (Ed.), Smrtelná předávkování nelegálními drogami a těkavými látkami v ČR - stručný souhrn a manuál pro monitorováni (Fatal overdoses related to illegal drugs and solvents in the Czech Republic - short overview of the situation and guidelines for monitoring). Metodika ed., Vol. 3 (pp. 58–71). Praha: Úřad vlády ČR.
61.
ZábranskýT.KorčišováB.2005Výsledky analýzy ohniskových skupin s terénními pracovníky v ÈR (The analysis of focus groups with Czech street workers active in the drug field). Praha: Národní monitorovací støedisko pro dorgy a drogové závislosti (Unpublished).
62.
ZábranskýT.MravčíkV.KorčišováB.ŘehákV.2006Hepatitis C virus infection among injecting drug users in the Czech Republic: Prevalence and associated factors. European Addiction Research, 12 (3), 151–160.
63.
ŠkutinaV.1969Prezidentův vězeň (Prisoner of the president) (1st ed.). Liberec: Severočeské nakladatelství.
